Indocyanine green labeling for optical and photoacoustic imaging of mesenchymal stem cells after in vivo transplantation by Filippi, M. et al.
Journal of Biophotonics
 
Indocyanine Green labeling for optical and photoacoustic imaging of Mesenchymal
Stem Cells after in vivo transplantation.
--Manuscript Draft--
 
Manuscript Number:
Full Title: Indocyanine Green labeling for optical and photoacoustic imaging of Mesenchymal
Stem Cells after in vivo transplantation.
Article Type: Full Article
Section/Category:
Keywords: Photoacoustic imaging;  Cell tracking;  Indocyanine Green;  stem cells;  Near Infrared
Fluorescence Imaging.
Corresponding Author: Miriam Filippi
University of Torino
Torino, Torino ITALY
Corresponding Author Secondary
Information:
Corresponding Author's Institution: University of Torino
Corresponding Author's Secondary
Institution:
First Author: Miriam Filippi
First Author Secondary Information:
Order of Authors: Miriam Filippi
Francesca Garello
Francesca Arena
Chiara Pasquino
Pierangela Giustetto
Federica Antico
Enzo Terreno
Order of Authors Secondary Information:
Abstract: The transplantation of Mesenchymal Stem Cells (MSCs) holds great promise for the
treatment of a plethora of human diseases, but new non-invasive procedures are
needed to monitor the cell fate in vivo. Already largely used in medical diagnostics, the
fluorescent dye Indocyanine Green (ICG) is an established dye to track limited
numbers of cells by optical imaging, but it can be visualized also by Photoacoustic
Imaging (PAI), which provides a higher spatial resolution than pure near infrared
fluorescence imaging (NIRF). Because of its successful use in clinical and preclinical
examinations, we chose ICG as PAI cell labeling agent. Optimal incubation conditions
were defined for an efficient and clinically translatable MSC labeling protocol, such that
no cytotoxicity or alterations of the phenotypic profile were observed, and a consistent
intracellular uptake of the molecule was achieved. Suspensions of ICG-labeled cells
were both optically and optoacoustically detected in vitro, revealing a certain variability
in the photoacoustic spectra. Intramuscular engraftments of ICG-labeled MSCs were
clearly visualized by both PAI and NIRF over few days after transplantation in the
hindlimb of healthy mice, suggesting that the proposed technique retains a
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Dear Editor,
we are submitting the manuscript entitled ’Indocyanine Green labeling for optical and
photoacoustic imaging of Mesenchymal Stem Cells after in vivo transplantation‘, that
reports on the use of the clinically approved fluorescent dye Indocyanine Green (ICG)
as labeling agent for the visualization of Mesenchymal Stem Cells (MSCs) by both
Photoacoustic and Fluorescence-based Imaging.
The present study was carried out at multiple levels, ranging from the in vitro
characterization of the technique to the in vivo applicative proof. Its novelty and
significance can be summarised as follows:
1)The choice of ICG as a safer alternative to conventional photoacoustic nano-sized
probes endows the protocol with maximized safety, thus increasing the potential for
clinical translatability. The optimal labeling conditions were determined, by identifying
the maximum exposure time to the agent that do not alter the viability, proliferation, and
marker profile of cells after incubation.
2)In these conditions, a good internalization was obtained, such that efficient optical
and photoacoustic imaging of cell suspensions in vitro was feasible, allowing to study
the PA spectral properties of ICG.
3)Intramuscular engraftments composed of limited numbers (3.0×105) of labeled
MSCs were successfully detected and monitored over time in vivo by both imaging
modalities, revealing considerable values of local contrast enhancement in the
engraftment site, persisting for days after cell deposition.
4)Even though the Fluorescence-based imaging of several types of ICG-labeled cells
was already reported (S. E. Boddington, et al., 2010; V. Sabapathy, et al., 2015), our
report shows its fundamental role in integrating the photoacoustic information.
5)The photoacoustic imaging allowed the video recording of the cell deposition into the
tissue during the transplantation, as well as the three-dimensional representation of the
engraftments, highlighting the potential utility of the technique in facilitating the
collection of data with real-time content and the characterization of the cell
engraftments.
Successful preclinical studies fuelled an increasing interest for therapeutic
interventions based on the transplantation of stem and progenitor cells, capable of
stimulating repair and regeneration of damaged tissue in several diseases affecting the
cardiovascular, central nervous, and musculoskeletal system. As the photoacoustic
imaging could provide good endogenous contrast among soft tissues and improved
spatial resolution with respect to pure optical detection of ICG, in our opinion this
efficient, safe and simple labeling technique retains a considerable potential in the field
of transplantation-focused research and therapy, possibly being relevant for the future
development of new strategies for the cell fate surveillance. As such, we believe this
contribution may be of interest to a broader readership.
Yours sincerely,
Enzo Terreno
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1.  Introduction 
Cell transplantation is an essential tool for biomedical 
research and a promising approach to achieve curative 
benefits in several pathologic scenarios.1 Specifically, due 
to their major role in regenerative therapies, treatment of 
immune disorders, and tissue repair, Mesenchymal Stem 
Cells (MSCs) are commonly involved in cell 
transplantation-based applications.[1-3] However, these 
strategies are not regarded as a first-line therapy yet, 
mainly because of the limited efficacy shown in several 
clinical studies.[1,4-5] Since the poor results are very 
often related to the lack of available information about the 
cell destiny after transplantation,[4-5] a growing interest 
has been dedicated to the development of innovative 
imaging procedures for non-invasive surveillance of the 
cell fate in vivo.[5-6] When the transplantation is 
performed into superficial tissues, also the imaging 
techiniques with limited penetration depth can be 
The transplantation of Mesenchymal Stem Cells (MSCs) holds 
great promise for the treatment of a plethora of human 
diseases, but new non-invasive procedures are needed to 
monitor the cell fate in vivo. Already largely used in medical 
diagnostics, the fluorescent dye Indocyanine Green (ICG) is 
an established dye to track limited numbers of cells by optical 
imaging, but it can be visualized also by Photoacoustic 
Imaging (PAI), which provides a higher spatial resolution than 
pure near infrared fluorescence imaging (NIRF). Because of 
its successful use in clinical and preclinical examinations, we 
chose ICG as PAI cell labeling agent. Optimal incubation 
conditions were defined for an efficient and clinically 
translatable MSC labeling protocol, such that no cytotoxicity 
or alterations of the phenotypic profile were observed, and a 
consistent intracellular uptake of the molecule was achieved. 
Suspensions of ICG-labeled cells were both optically and 
optoacoustically detected in vitro, revealing a certain 
variability in the photoacoustic spectra acquired by varying the 
excitation wavelength from 680 to 970 nm. Intramuscular 
engraftments of ICG-labeled MSCs were clearly visualized by 
both PAI and NIRF over few days after transplantation in the 
hindlimb of healthy mice, suggesting that the proposed 
technique retains a considerable potential in the field of 
transplantation-focused research and therapy. 
 
 
Stem cells were labeled with the FDA approved fluorescent 
dye Indocyanine Green (ICG), and detected by both 
photoacoustic and optical imaging, enabling to monitor the cell 
fate safely, in dual modality, and with good sensitivity and 
improved spatial resolution. 
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successfully employed to monitor the cell engraftment 
and the local biological reaction to the therapy.[7-11] 
Both Optical Imaging (OI) and Ultrasonic Imaging (US) 
suffer from wave scattering into living tissue, but display 
other complementary properties.[12-13] Near Infrared 
Fluorescence (NIRF) imaging is one of the most used OI 
modalities and it is endowed with elevated sensitivity, but 
lacks spatial resolution. On the other side, US imaging 
provides a satisfactory sub-mm spatial resolution at 
centimeters depth and intermediate sensitivity.[14] 
Photoacoustic Imaging (PAI) merges the advantages of 
the two techniques and compensates their limitations, thus 
paving the way towards new imaging applicative 
horizons.[12-13] So far, PA cell imaging has been mostly 
performed by loading cells with gold and carbon-based 
nano-objects,[15-18] offering a considerable efficiency in 
contrast detection, but with documented episodes of 
cytotoxicity and adverse immune reactions.[16,19-20] 
However, also small molecules (either fluorescence 
quenchers or low quantum-yield emitters) display 
properties of interaction with the electromagnetic 
radiation leading to phototermal conversion and ultrasonic 
emission.[21] Among fluorescent compounds, we chose 
Indocyanine Green dye (ICG), a tricarbocyanine dye that, 
when dissolved in aqueous solution in the micromolar 
range, exhibits absorbance and emission peaks at 780 nm 
and 830 nm, respectively.[22-23] Since its FDA approval 
for human use in 1959,[22] this molecule has been 
clinically employed for a myriad of medical purposes, 
including phototherapy, ophthalmic angiography, 
laparoscopy, hepatic function and cardiac output 
determination, sentinel lymph node detection in oncology, 
vascular and brain surgery, and several others.[22-27] 
With a fluorescence quantum yield of about 10% in water, 
ICG can non-radiatively release ≈ 90% of its excited 
energy in the form of heat,[28] thus becoming a popular 
option for the surface functionalization of particles 
detectable by both NIRF and PAI.[15,21] ICG has already 
been proposed as cell labeling agent in cell tracking by 
NIRF,[29-30] but it has never been envisaged for the 
photoacoustic cell visualization in its molecular form. 
Besides retaining superior imaging potential than pure 
NIRF, PAI of cells loaded with ICG would also offer a 
safer labeling route than current standard probes. 
Therefore, in the present study, this dye was selected as 
dual fluorescence and optoacoustic cell tracer to label 
murine bone marrow-derived MSCs. After having defined 
the optimal labeling conditions, the characteristics and 
persistence of NIRF and PA signals were monitored either 
in in vitro cell suspensions or in vivo engraftments 
obtained by intramuscular transplantation in healthy mice.  
2.  Experimental  
2.1 Animal Care and Use 
Eight weeks old female C57BL/6J mice with similar 
weight (around 20-21 g) were used for the in vivo tests. 
All mice involved in the study were obtained from Charles 
River Laboratories (Calco, LC, Italy) and maintained in 
standard housing conditions, with water and standard 
rodent chow ad libitum and 12 h light/dark cycle. 
Anesthesia was provided by intramuscular injection of a 
combination of tiletamine/zolazepam (Zoletil 100; 
Virbac, Milan, Italy) at 20 mg/kg and xylazine (Rompun; 
Bayer, Milan, Italy) at 5 mg/kg. For information about the 
histological examination, see the Supporting Information. 
Each animal group was composed of at least 6 individuals. 
All procedures were approved by the Italian Ministry of 
Health. 
2.2 Chemicals 
All the materials necessary for cell culture were purchased 
from Lonza (Lonza Sales AG, Verviers, Belgium). The 
ICG dye was purchased from MP Biomedicals (Santa 
Ana, CA, USA), whereas all other chemicals from Sigma 
Chemical Co. (St Louis, MO, USA) and were used as 
received.  
2.3 MSC culture  
MSCs were isolated from the bone marrow of male 
C57BL/6J mice (age: 7-9 weeks, weight: 22-28 g). 
Briefly, femurs and tibias were excised, and flushed with 
RPMI w/o Red Phenol supplemented with 10% FBS to 
harvest the bone marrow cells, which were then cultured 
into Minimal Essential Medium Eagle Alpha 
Modification supplemented with penicillin (100 U/ml), 
streptomycin (100 μg/ml), FBS (10%) and glutamine (2 
mM). After 4 days, the MSCs were selected on the basis 
of their adherence to plastic, before they underwent a 
magnetic immune cell sorting with Microbeads 
conjugated to monoclonal rat antimouse/human CD11b 
antibody (Miltenyi Biotec GmbH, Bergish Gladbach, 
Germany) at day 10 to further remove CD11b+ 
granulocytic cells.  
2.4 Cell labeling protocol 
The ICG-labeling solution was prepared by completely 
dissolving the dye powder into Dimethyl Sulfoxide 
(DMSO), before adding the FBS-free culture medium (the 
v/v of DMSO/medium was 1:6). A final ICG 
concentration of 0.25 mg/ml was used in all experiments. 
MSCs were detached from flasks, added with the pre-
warmed ICG-labeling solution, and left at 37°C for 
variable time ranges (ranging from 2 minutes to 6 hours). 
After labeling, the excess of dye was removed by washing 
the cells three times with Phosphate Buffered Saline 
(PBS).  
2.5 Cell viability and proliferation rate 
Cell viability was estimated by using the Trypan Blue 
exclusion assay. The reported viability percentage value 
represents the average ratio between the number of viable 
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cells Nv and the total number of cells Ntot (Nv/Ntot × 100). 
Similarly, for proliferation tests the cells were seeded after 
labeling and maintained in standard culture conditions for 
different time ranges (up to 8 days), before being counted. 
The proliferation ability is expressed as the average ratio 
between the number of cells at each time point Nt and the 
number of cells present at the beginning of the experiment 
N0 (Nt/N0). 
2.6 Flow cytometry 
Cells were resuspended in PBS supplemented with 0.1% 
BSA and incubated with fluorochrome-conjugated 
monoclonal antibodies (mAb) for 30 min at 4°C. The 
following mAbs (final dilution: 1/20) were used: anti-
CD29-(PE), anti-CD44-APC, anti-CD11b-FITC, anti-
CD90-(PE) (BD Bioscience Pharmingen, San Jose, CA, 
USA), anti-Sca1-(PE) (Cedarlane, Burlington, Ontario, 
Canada), and anti-CD105-PE (MACS Miltenyi Biotec, 
San Diego, CA, USA). The fluorescence was measured 
using the FACS Calibur flow cytometer equipped with 
CellQuest software (BD Biosciences).  
2.7 Optical absorbance and emission of labeled 
cells 
The cell uptake of ICG was estimated by fluorimetry. 
Briefly, the labeling incubation was carried on for 60 
minutes. After exhaustive washing, cells were counted, 
suspended at the final concentration of 3.0×106 cells/ml in 
PBS, sonicated by using a Bandelin Sonoplus Sonicator 
(20kHz, 20 W, 30s), and analysed by a FluoroMax-4 
Spectrofluorometer (Horiba Scientific, Edison New 
Jersey, USA) equipped with the driving software 
FluorEssenceTM for Windows. The number of ICG 
molecules internalized by the single cell was estimated on 
the basis of the signal intensity values measured at 803 nm 
and reported on the calibration curves which were 
previously obtained. The experiment was repeated four 
times. 
2.8 Cell transplantation 
Healthy male C57BL/6J mice (weight: 25-28 g, age: 10-
12 weeks) were anaesthetized, and their hindlimbs were 
shaved. After labeling, 3.0x105 MSCs were collected, 
suspended in 100 µL of PBS, and injected into the 
gastrocnemius muscle of the right hindlimb by using a 1-
ml syringe with a 25-G × 5/8-in needle (BD, Franklin 
Lakes, NJ). Equivalent numbers of control unlabeled cells 
were transplanted into the left hindlimb. 
2.9 Combined ultrasound and photoacoustic 
(US/PA) imaging 
PAI was performed by using a VisualSonics Vevo 2100 
LAZR Imaging Station (VisualSonics, Inc., Toronto, 
Canada) equipped with a LZ250 transducer operating at 
21 MHz frequency that incorporates photoacoustic 
imaging into high-resolution ultrasound imaging. Cell 
suspensions were loaded onto a custom-made phantom for 
photoacoustic in vitro acquisitions, equipped with 
stretched plastic capillaries to contain liquid samples, 
further surrounded by solified agarose gel to provide 
favourable interface for US propagation. The 
photoacoustic transducer was set perpendicularly to the 
capillaries, such that images reproducing their axial 
sections were acquired. The PA signal intensity was 
recorded by switching the excitation over the wavelength 
range included between 680 and 960 nm, and graphed as 
a spectrum. The normalized photoacoustic spectrum for 
each sample was obtained by subtracting the contribution 
of the blank (either PBS or unlabeled cells suspended in 
PBS) at each wavelength λ, as follows: 
 
𝑁𝑃𝐴𝜆 = 𝑃𝐴 𝑠𝑎𝑚𝑝𝑙𝑒 𝜆 −  𝑃𝐴 𝑐𝑡𝑟𝑙 𝜆 
 
where NPA is the normalized photoacoustic signal, 
PAsample and PActrl stand for the photoacoustic intensity 
at each wavelength λ of each sample or ctrl, respectively. 
Each experiment was repeated in triplicate. 
For in vivo imaging, anaesthetized animals were 
accurately shaved on their hindlimbs. Combined US/PA 
images were obtained by overlaying photoacoustic 
intensities on the ultrasound images with user-defined 
grayscale thresholds. PA intensity values measured on the 
transplantation site of labeled cells (right hindlimb) were 
normalized with respect to the signal recorded on the same 
anatomical region of the left hindlimb after the injection 
of the control unlabeled cells, as reported in the following 
formula: 
 
 
 
where PAright and PAleft represent the photoacoustic 
signal measured in the right and left hindlimb at different 
wavelengths included between 680 and 960 nm, 
respectively. Spectra recorded before the cell 
transplantation (Pre-Injection) were provided to show the 
local endogenous photoacoustic baseline of the muscular 
tissue. The signal intensity quantification was carried out 
at fixed excitation wavelength (810 nm). 
2.10 Optical imaging 
The photon emission from the labeled cells was measured 
in vitro on the Pearl Imager (LI-COR Biosciences, 
Lincoln, NE) with preset near infrared excitation (710–
760 nm) and emission (810–875 nm) pass band filters to 
evaluate the ICG signal. The in vivo studies were carried 
out on the IVIS Spectrum Whole Animal Imaging System 
(Perkin Elmer Inc., Waltham, Massachusetts, USA). The 
animals were irradiated with filter light of wavelength 745 
nm, and an image of emission intensity was collected at 
840 nm (field of view = 14 cm, fstop = 2, binning = 
medium, exposure time = auto). As for the photoacoustic 
experiments, the fluorescence-imaging signal intensity 
values were measured on the transplantation site of 
labeled cells (right hindlimb), and normalized with respect 
𝑃𝐴 𝐸𝑛ℎ =
𝑃𝐴𝑟𝑖𝑔ℎ𝑡 − 𝑃𝐴𝑙𝑒𝑓𝑡
𝑃𝐴𝑙𝑒𝑓𝑡
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to control unlabeled cells (left hindlimb). The 
Fluorescence Imaging Enhancement (FLIenh) was 
expressed as: 
 
 
where FLIright and FLIleft represent the fluorescence 
intensity measured in the right and left hindlimb, 
respectively. 
 
2.11 Statistical analysis 
All data were presented as Mean Values ± Standard Error 
of the Mean (MV±SE). Statistical significance was 
determined by either the unpaired Student t-test or the 
Analysis of the Variance (ANOVA) test, as indicated in 
each graph. The p-values ≤ 0.05 and 0.01 were marked as 
* and **, respectively.  
3.  Results  
3.1 Optimization of the cell labeling procedure 
The labeling procedure was performed by detaching and 
incubating MSCs with ICG-containing medium at 37°C 
(Figure 1A). According to previous studies,[31] a final 
ICG concentration of 0.25 mg/mL was selected to perform 
all labeling experiments, and the procedure was optimized 
by subjecting the MSCs to different incubation times. For 
the longest incubation times, an inverse proportionality 
between cell viability and duration of the labeling was 
observed (Figure 1B), with a significant (t-test p-value ≤ 
0.01) viability reduction specifically induced by 
incubations lasting 3 and 6 h (18.9% and 24.3%, 
respectively). In these conditions, cells also showed 
impaired proliferation ability (Figure 1C): a decreased 
fraction of viable cells was found at different time points 
after labeling, culminating at day 8 when the proliferation 
rate for both the conditions was dramatically reduced 
(33.3 % and 40.7 %, respectively, ANOVA p-value ≤ 
0.01) with respect to control cells. In the other tested 
labeling times, no relevant changes in viability were 
detected, therefore suggesting that an incubation time of 1 
h may be considered optimal for safe labeling in 
maximum loading conditions. The molecular 
internalization rate after 1h incubation was therefore 
determined by estimating the ICG content per cell via 
fluorimetric assay directly on labeled cell suspensions, 
such that an uptake of (1.7 ± 0.4)×1010 molecules/cell was 
calculated, corresponding to an internalization efficiency 
of approximately 0.9 ± 0.2 %. Finally, as observed by flow 
cytometry, the 1 h exposure to ICG did not induce any 
alteration in the expression profile of cell surface markers 
(Figure 1D), revealing a complete retention of the MSC 
phenotype.  
3.2 In vitro imaging 
The photoacoustic and fluorescent properties of ICG were 
preliminary investigated with the respective imaging 
systems (Figure 2 and 3). The photoacoustic signal of 
differently concentrated ICG aqueous solutions in a 
submillimolar range was acquired by tuning the excitation 
wavelength from 680 to 970 nm in order to study the PA 
sensitivity and spectrum in vitro (Figure 2A and B). The 
intensity at the initial phase of the spectral profile 
increased with the dye concentration, and even if a 
photoacoustic detection limit of 25 µM was identified 
elsewhere on a different PA imaging station,[32] in our 
setup we were able to clearly detect the molecule at a 
concentration of 15 µM (Figure 2A) according to what 
was already reported by others using the same 
instrument.[33] The PA signal tended to drop as the 
excitation was swept to high wavelengths (> 830 nm) and 
became eventually negligible at 950 nm, even at the 
highest concentration tested (i.e., 1 mM). However, a 
certain concentration-dependent variability in the spectral 
shapes was observed: whereas the 1 mM ICG presented a 
sharp peak centered at 710 nm, in diluted solutions the 
molecule displayed a more flattened spectral profile 
characterized by the presence of two peaks. Further 
lowering the concentration, a more defined peak at 800 
nm appeared. Since this observation approximately 
matched the finding of a recurrent main peak at around 
810 nm reported by Park et al.[32], we selected this 
excitation wavelength as reference value to perform the 
signal quantification and acquire representative images. In 
order to test the effects of a possible interaction between 
ICG and cellular components, samples containing the dye 
at variable concentrations and a fixed number (3.0×105) of 
MSCs were analyzed immediately after mixing (Figure 
2C and D). Interestingly, in the presence of cells the PA 
signal intensity at the spectral initial phase increased for 
almost all the samples (ca. 2-fold increase at 15 and 100 
µM and even 3-fold at 1 mM ICG). Although some 
variations in the spectral shape were observed at the 
highest investigated ICG concentration, for the 
micromolar ICG the main peak wavelength shifted within 
the 800-820 nm interval, confirming that the PA 
excitation may be performed at maximum efficacy in this 
range. Finally, also cells labeled with the ICG according 
to our optimized protocol were analyzed (Figures 2E and 
2F). This experiment was carried out by resuspending 
3.0×105 ICG-labeled MSCs in decreasing PBS volumes, 
thus varying both the cell density and the final volume of 
the suspension. We assumed that the ICG amount uptaken 
by the cells during the labeling procedure led to a final dye 
𝐹𝐿𝐼 𝐸𝑛ℎ =
𝐹𝐿𝐼𝑟𝑖𝑔ℎ𝑡 − 𝐹𝐿𝐼𝑙𝑒𝑓𝑡
𝐹𝐿𝐼𝑙𝑒𝑓𝑡
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concentration in the µM range, as it was previously 
determined by fluorimetry. Indeed, the spectral shape of 
the labeled MSCs recapitulated the one observed in the 
presence of the micromolar dye, being characterized by a 
main peak at about 820 nm. Very interestingly, the ICG 
internalized within cells produced a strong PA signal, 
which increased of ca. 25 % and 85 % as compared to the 
100 µM ICG sample with and without cells, respectively. 
Indeed, the PA signal intensity was comparable to that of 
the 1 mM ICG mixed with cells (Figure 2G), thus 
indicating that an optoacoustic enhancement can likely be 
obtained through the intracellular compartimentalization 
of the dye. Interestingly, only subtle variations in the PA 
signal intensity were found when labeled cells were 
differently concentrated into PBS (Figures 2E and 2F), 
possibly suggesting that phenomena of liquid reabsorption 
that commonly follow the inoculation of cells into tissue 
might only induce minimal effects on the signal intensity. 
All the samples were also analyzed in terms of NIRF 
intensity, as expressed in Average Radiant Efficiency 
(Figure 3). For both ICG aqueous solutions and ICG-cell 
mix, the concentration-dependent initial increase of the 
fluorescence peaked at 50 μM, and was followed by a fast 
decrease (Figures 3A and 3B) in accordance to previous 
studies indicating that dye concentrations exceeding 200 
µM are not detectable due to quenching phenomena.[32] 
The fluorescent behaviour of ICG only differed at 100 
µM, where a slightly reduced emission occurred in the 
presence of cells. Interestingly, in the suspensions of ICG-
labeled cells (Figures 3C and 3D)  the NIRF contrast 
enhancement calculated over the baseline (unlabelled 
cells) at the lowest and highest cell concentrations 
(namely 3000 and 15000 cell/µl) corresponded to +300 
and 220%, respectively, therefore showing a mild 
reduction of the fluorescent emission towards high cell 
densities. Nonetheless, these signal variations were 
recorded in the same magnitude range of intensity, 
reflecting a relatively limited potential of the cell density 
to affect the NIRF emission. Additionally, we also 
demonstrated that both the photoacoustic and fluorescent 
emissions increased with the incubation time (Figure 
S1A), but whereas the PA signal amplitudes recorded on 
suspensions of cells labeled for 2 minutes were not 
distinguishable from the baseline, the fluorescent signal 
could be detected in all the tested conditions (Figure S1B 
and C). Finally, the PA and NIRF signal intensity from 
cells incubated for 1 h was significantly (ANOVA, p-
value < 0.01) higher with respect to all other conditions 
(Figures S1A and S1B), confirming this incubation time 
as optimal for imaging efficiency.  
3.3 In vivo imaging  
The in vivo study was carried out by locally transplanting 
3.0×105 ICG-labeled MSCs into the gastrocnemius 
muscle of the right hindlimb of healthy C57BL/6J mice. 
The site of cell deposition was clearly detected by US 
imaging (B-mode, 21 MHz), as a consequence of the 
change in the acoustic impedance determined by the dense 
inoculated cell mass (Figure 4A). The PA signal intensity 
generated by the ICG-MSCs was normalized over the 
local endogenous baseline recorded in the left hindlimb of 
the animal where the transplantation of control unlabeled 
cells was performed (representative pictures in Figure 
4B) and expressed as photoacoustic enhancement (PAEnh, 
see Experimental for details). The PAEnh was measured 
over the entire range of excitation wavelengths 
immediately after cell transplantation, then monitored 
over time, and reported as PA spectrum in Figure 4C. 
Interestingly, immediately and 4 hours post-injection, the 
maximum peak recorded in the photoacoustic spectra was 
shifted towards high excitation wavelength values (890 
and 920 nm, respectively), whereas from day 1 to day 4, 
the spectral shape reproduced the one observed  in vitro 
with a maximum enhancement centered at around 810 nm 
(Figures 4D and 4E). Finally, the normalized PA spectra 
acquired 7 days post injection presented a flat shape 
without any discernable peak. Figure 4F displays the 
time-dependent variation of the signal as quantified at 
both 810 nm and the wavelength corresponding to the 
maximum peak recorded in each spectrum, whereas 
Figure 4G shows representative images of the time 
evolution of PA emission in regions of interest (ROIs) at 
tissue depth comprised between 1 and 5 mm. Moreover, 
the entire procedure of cell injection was caught on video 
(Movie S1) and 3D reconstructions of the ICG-MSC 
engraftment in the right calf were elaborated using 
Vevo®Lab 1.7.2 software (Figure S2 and Movies S2 and 
S3). Immediately after cell transplantation, a considerably 
high PA amplitude was measured in the inoculation site 
(Figures 4C and 4F). By summing up the PA signal areas 
as calculated on bidimensional ROIs drawn in consecutive 
images over the entire muscular region, an engraftment 
volume of around 70 mm3 was estimated, which is 
consistent to the injection procedure of a 100 µl cell 
suspension. Then, a progressive time-dependent decrease 
in the signal intensity occurred, revealing that the labeled 
MSCs could be optoacoustically detected until 3 days 
before the loss of the ICG-related signal and the 
prevalence of unspecific signal components let the 
contrast enhancement become almost negligible (Figure 
4F). After each PA acquisition, the mice underwent NIRF 
imaging in order to assess the fluorescent contrast 
enhancement (FLIEnh) produced by the transplanted cells 
(Figures 5A and 5B). Interestingly, before progressively 
fading over days (likely due to the dye degradation and 
washout), the FLIEnh values followed an initial rising trend 
during the first 24 h after the engraftment deposition. The 
coincident observation of extremely high PA amplitudes 
(Figures 4C and 4F) suggests that at early time points the 
strong intermolecular interactions among ICG molecules 
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contribute to  the quenching of the fluorescence, but 
results at the same time into an increase of the 
photoacoustic effect, due to photothermal conversion by 
nonradiative decay.[33] Finally, the time limit for the 
engraftment detection by NIRF matched that one enabled 
by the optoacoustic decay (namely, 3 days p.i.). Similar 
conclusions derived from an additional series of 
experiments perfomed by transplanting a higher cell 
number (1.0×106 cells, Figures S3 and S4). As expected, 
a more intense and persistent contrast enhancement was 
obtained in both techniques, pushing further the detection 
limit day. In particular, a photoacoustic signal was still 
detected 7 days after transplantation, which truly 
corresponded to sparse residual ICG-labeled MSCs, as 
proved by histological examination in the inoculation site 
(Figure S5).  
4.  Discussion 
According to pre-clinical and clinical research conducted 
thus far, cell imaging should be assimilated into more 
studies focused on the use of cell-transplantation for 
therapeutic purposes.[30] In fact, the imaging techniques 
that facilitate the unambiguous in vivo identification and 
characterization of the cell engraftments are invaluable for 
assessing the survival and the functional integration of 
exogenous cells, and for optimizing the delivery as well. 
The present work aimed at addressing these issues by 
merging the advantages offered by the well-known and 
safe profile of ICG with the emergent technique of PAI. 
For the first time the potential application of the free ICG 
as cell labeling agent and photoacoustic tracer was 
explored. As already done by Uthaman et al.,[34] the PA 
visualization of the cell engraftment was paralleled by 
NIRF acquisition in order to perform a comparative study 
of the two imaging modalities. Despite the minor toxicity 
and the related advantages for in vivo applications, ICG 
exhibits very complex optical properties. Besides being 
largely dependent on the solvent, concentration and 
interaction with other molecules,[22,23,26] the absorption 
and emission spectra are also broad and overlapping, thus 
causing a significant re-absorption of the fluorescence by 
the dye itself. Moreover, as extensively reviewed by 
Desmettre et al.,[22] the molecule can be affected by 
photodegradation and, at high concentrations, its effective 
absorption does not linearly increase with concentration 
due to the dye aggregation. More in details, because of its 
amphiphilic properties, ICG is mainly present in the 
monomer form at concentrations below 5 µM, whereas 
over 100 µM the oligomer form prevails. The ICG 
oligomers display a weaker fluorescence yield, affecting 
the absorbance spectrum. Thus, a dramatic boost of the 
ICG concentration is not expected to result in a substantial 
signal enhancement, as we also noticed by both PA and 
NIRF imaging. Alternatively, in order to increase the 
quantum yield and the fluorescence intensity of the 
carbocyanine dye, a stable interaction with phospholipids 
could be envisaged.[35] Such crucial aspect has been 
extensively exploited for the preparation of several ICG-
loaded nanosystems thus far,[35-36] and coherently, in 
our experiments the simple mixture of ICG with cells 
produced a marked increase in the PA intensity values, 
which could be possibly ascribed also to its interaction 
with cell membranes. On the other hand, the additional PA 
increase we observed in the cells after incubation with the 
dye could be hypothetically justified also by a mechanism 
of oligomer formation occurring as a consequence of the 
intracellular compartmentalization. Importantly, in the 
present study a cell labeling procedure advantageous in 
terms of both cellular uptake and generated imaging signal 
was proposed. Remarkably, in these conditions the 
exposure to the contrast agent did not produce any 
relevant alteration in the cell profile, suggesting that ICG-
labeled MSCs may retain their therapeutic efficacy. 
Finally, when it comes to in vivo use of the ICG, the 
results interpretation is further complicated by the 
intricacy of molecular interactions with the various 
components of the biological environment.[22,34] Here, 
the photoacoustic behaviour of the dye was investigated 
in complex circumstances involving concentration-
dependent effects, internalization by cells, interactions 
with cell components, and deposition into living tissues. 
Since several common applicative scenarios require the 
transplantation of hundreds of thousands of MSCs,[37-38] 
we representatively performed our experiments by 
labeling and monitoring 3.0×105 cells to verify whether 
this procedure could be of effective utility and practical 
interest. Our in vivo proof of principle productively 
demonstrated that cells can be visualized into living tissue 
by both PAI and NIRF over few days after transplantation. 
Though the ICG labeling enables the longitudinal 
monitoring of the engrafted cells, the observation times 
are shorter than for the PA-detectable nano-objects 
reported in literature,[17] most likely due to the faster 
release of the dye from cells, as already observed by 
Boddington et al.[29] However, also the risks connected 
to the long-term tissue accumulation of exogenous 
compounds have to be carefully considered, especially in 
proximity of delicate therapeutic cell grafts. Additionally, 
we established that a reliable quantification of the 
photoacoustic signal at 810 nm can be performed only 
starting from 24 h after transplantation, since the prior 
time points are affected by a bathochromic shift of the 
ICG signal, possibly related to the extremely high local 
concentration of the dye. As in the same time window we 
detected the co-presence of PA peaks centred at around 
900 nm and reduced NIRF signal, we argued that the two 
phenomena may be correlated by an exchange of the 
emission mechanism (i.e. from radiative to acoustic), 
likely depending on the ICG concentration. However, in 
general terms, it also has to be taken into account that 
immediately or shortly after surgery, tissues frequently 
display imaging artefacts caused by haemorrhages and/or 
micro air bubbles deposition, which make it arduous to 
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define the real source of the observed contrast, thus 
preventing an accurate quantification in early monitoring. 
This aspect becomes more relevant when the local 
transplantation is carried out in the absence of specific cell 
vehicles (like hydrogels), such that the injection procedure 
likely introduces air into tissue along the needle path.[39] 
Therefore, we conclude that the optimal imaging window 
offered by the present protocol corresponds to a time 
range comprised between 1 and 3 days post-
transplantation, which could ideally turn out to be helpful 
in prospective clinical or pre-clinical applications to: (i) 
ascertain the successful outcome of surgical cell 
deposition, (ii) describe the extension and aspect of the 
engraftment, and (iii) follow the cell migration in 
relatively superficial anatomical areas. Finally, we 
demonstrated that NIRF imaging substantially 
recapitulated and validated the information obtained by 
PAI, thus highlighting the pivotal role of the dual-
modality approach in strengthening the reliability and 
clinical utility of ICG-guided MSC imaging. In the past 
decade, researchers have been tracking transplanted cells 
in real-time in vivo mainly by Magnetic Resonance 
Imaging (MRI), Positron emission Tomography (PET), 
Single Photon Emission Tomography (SPECT), and 
Optical Imaging, facing crucial issues in regard to image 
acquisition time, method sensitivity, radiation-related 
damage, short half-life of radioisotopes, genetic 
manipulation to introduce reporter genes, and three 
dimensional anatomical imaging capability.[5-11,39] The 
high spatial resolution integrated with elevated sensitivity 
and moderate tissue penetration depth, the FDA-approved 
tracer and the fast image acquisition make of the herein 
proposed protocol an attractive option to further develop 
the techniques of direct stem cell labeling towards the 
clinical dimension, by satisfying almost all the ideal 
translational requirements.[40]  
5.  Conclusion 
In summary, the ICG was successfully used as PA-NIRF 
dual-mode contrast agent to label, visualize, and monitor 
MSCs both in vitro and in vivo. Proper cell labeling 
conditions were selected such that the cell uptake was 
maximized, and cell viability, proliferation, and 
phenotypic features were preserved. Since the number of 
MSCs involved in several experimental circumstances is 
usually either similar or higher than that used here,[35-36] 
we conclude that in a forward-looking vision this 
technique retains a considerable potential  for 
transplantation-focused research and therapy by providing 
the in vivo cell fate surveillance with safety, real time 
content, good endogenous contrast among soft tissues and 
improved spatial resolution. 
Supporting Information  
Additional supporting information may be found in the 
online version of this article at the publisher’s website.  
 
 
Acknowledgements Dr Giovanni Valbusa (Ephoran), 
Lorenzo Ariotti (Bracco Imaging Spa), and Dr Marta Tapparo 
(University of Turin) are gratefully acknowledged for their 
valuable contribution to fluorescence microscopy imaging and 
histological examination. FUV is gratefully acknowledged. 
 
Author biographies please see Supporting 
Information online. 
References 
1. E. Buzhor , L. Leshansky, J. Blumenthal, H. Barash, D. 
Warshawsky, Y. Mazor, and R. Shtrichman, Regen Med 9, 
649-672 (2014). 
2. X. Wei, X. Yang, Z. P. Han, F. F. Qu, L. Shao, and Y. F. 
Shi, Acta Pharmacol Sin 34, 747-754 (2013).  
3. M. Das, I. B. Sundell, and P. S. Koka, J Stem Cells 8, 1-16 
(2013). 
4. C. A. Herberts, M. S. Kwa, and H. P. Hermsen, J Transl 
Med 9, 29 (2011). 
5. A. K. Srivastava and J. W. Bulte, Stem Cell Rev 10, 127-
144 (2014).  
6. M. E. Kupfer and B. M. Ogle, Biotechnol J 10, 1515-1528 
(2015). 
7. Y. Zhao, A. J. Bower, B. W. Graf, M. D. Boppart, and S. 
A. Boppart, Methods Mol Biol 1052, 57-76 (2013). 
8. E. J. Sutton, T. D. Henning, B. J. Pichler, C. Bremer, and 
H. E. Daldrup-Link, Eur Radiol 18, 2021-2032 (2008).  
9. Z. Yang, Q. Zeng, Z. Ma, Y. Wang, and X. Xu, J Vis Exp 
31, 10.3791/1388 (2009). 
10. J. E. Kim, S. Kalimuthu, and B. C. Ahn, Nucl Med Mol 
Imaging 49, 3-10 (2015).  
11. Y. Hakamata, T. Murakami, and E. Kobayashi, 
Transplantation 81, 1179-1184 (2006). 
12. R. Bouchard, O. Sahin, and S. S. Emelianov, IEEE Trans 
Ultrason Ferroelectr Freq Control 61, 450-466 (2014).  
13. J. Kim, D. Lee, U. Jung, and C. Kim, Ultrasonography 34, 
88-97 (2015).  
14. L. Cunha, I. Horvath, S. Ferreira, J. Lemos, P. Costa, D. 
Vieira, D. S. Veres, K. Szigeti, T. Summavielle, D. Máthé, 
and L. F. Metello, Mol Diagn Ther 18, 153-173 (2014).  
15. X. Yang, E. W. Stein, S. Ashkenazi, and L. V. Wang, Wiley 
Interdiscip Rev Nanomed Nanobiotechnol 1, 360-368 
(2009). 
16. S. Manohar, C. Ungureanu, and T. G. Van Leeuwen, 
Contrast Media Mol Imaging 6, 389-400 (2011). 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
Journal header will be provided by the publisher 8 
 
 Copyright line will be provided by the publisher 
17. S. Y. Nam, L. M. Ricles, L. J. Suggs, and S. Y. Emelianov, 
PLoS One 7(5):e37267, 10.1371/journal.pone.0037267 
(2012). 
18. H. Gong, R. Peng, and Z. Liu 65, 1951-1963 (2013).  
19. A. J. Andersen, P. P. Wibroe, and S. M. Moghimi, Adv 
Drug Deliv Rev 64, 1700-1705 (2012).  
20. Z. Krpetić, S. Anguissola, D. Garry, P. M. Kelly, and K. A. 
Dawson, Adv Exp Med Biol 811, 135-156 (2014). 
21. S. Zackrisson, S. M. Van de Ven, and S. S. Gambhir, 
Cancer Res 74, 979-1004 (2014).  
22. T. Desmettre, J. M. Devoisselle, and S. Mordon, Surv 
Ophthalmol 45, 15-27 (2000). 
23. B. Yuan, N. Chen, and Q. Zhu, J Biomed Opt 9, 497-503 
(2004). 
24. J. T. Alander, I. Kaartinen, A. Laakso, T. Pätilä, T. 
Spillmann, V. V. Tuchin, M. Venermo, and P. Välisuo, Int 
J Biomed Imaging 2012:940585, 10.1155/2012/940585 
(2012).  
25. H. Abe, T. Mori, T. Umeda, M. Tanaka, Y. Kawai, T. 
Shimizu, H. Cho, Y. Kubota, Y. Kurumi, and T. Tani, Surg 
Today 41, 197-202 (2011).  
26. C. Jonak, H. Skvara, R. Kunstfeld, F. Trautinger, and J. A. 
Schmid, PLoS One 6(8):e23972, 
10.1371/journal.pone.0023972 (2011).  
27. R. Alford, H. M. Simpson, J. Duberman, G. C. Hill, M. 
Ogawa, C. Regino, H. Kobayashi, and P. L. Choyke, Mol 
Imaging 8, 341-354 (2009). 
28. M. Ogawa, N. Kosaka, P. L. Choyke, and H. Kobayashi, 
Cancer Res 69, 1268-1272 (2009). 
29. S. E. Boddington, T. D. Henning, P. Jha, C. R. Schlieve, L. 
Mandrussow, D. DeNardo, H. S. Bernstein, C. Ritner, D. 
Golovko, Y. Lu, S. Zhao, and H. E. Daldrup-Link, Cell 
Transplant 19, 55-65 (2010). 
30. V. Sabapathy, J. Mentam, P. M. Jacob, and S. Kumar, Stem 
Cells Int 10.1155:2015, 10.1155/2015/606415 (2015).  
31. J. D. Ho, R. J. Tsai, S. N. Chen, and H. C. Chen, Br J 
Ophthalmol 88, 556-559 (2004). 
32. S. Park, J. Kim, M. Jeon, J. Song, and C. Kim, Sensors 
(Basel) 14, 19660-19668 (2014).  
33. G. Ferrauto, F. Carniato, E. Di Gregorio, L. Tei, M. Botta, 
and S. Aime, Nanoscale 9, 99-103 (2017). 
34. S. Uthaman, J. S. Bom, H. S. Kim, J. V. John, H. S. Bom, 
S. J. Kim, J. J. Min, I. Kim, and I. K. Park, J Biomed Mater 
Res B Appl Biomater 104, 825-34 (2016). 
35. J. C. Kraft and R. J. Y. Ho, Biochemistry 53, 1275-1283 
(2014). 
36. E. Portnoy, N. Vakruk, A. Bishara, M. Shmuel, S. 
Magdassi, J. Golenser, and S. Eyal, Theranostics 6, 
167-76 (2016). 
37. K. Serigano, D. Sakai, A. Hiyama, F. Tamura, M. Tanaka, 
and J. Mochida, J Orthop Res 28, 1267-1275 (2010).  
38. K. Mareschi, D. Rustichelli, R. Calabrese, M. Gunetti, F. 
Sanavio, S. Castiglia, A. Risso, I. Ferrero, C. Tarella, and 
F. Fagioli, Stem Cells Int 2012:920581, 
10.1155/2012/920581 (2012). 
39. E. Bull, S.Y. Madani, R, Sheth, A. Seifalian, M. Green, and 
A. M. Seifalian, Int J Nanomedicine 9, 1641-1653 (2014). 
40. J. V. Frangioni and R. J. Hajjar, Circulation 110, 3378-3383 
(2004). 
 
 
  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
9 Author, author, and Author: Short title 
Copyright line will be provided by the publisher 
Figures 
 
Figure 1. Cytotoxic effects induced by the ICG. (A) Schematic diagram of the adopted procedure 
for ICG-labeling and in vivo detection of MSCs. (B) Cell viability estimated on MSCs incubated with 
0.25 mg/ml ICG-containing medium for different time ranges. Cells incubated with culture medium 
were used as control. (C) Proliferation rate of MSCs subjected to the ICG-labeling for different time 
ranges (0 h refers to control cells that did not undergo the labeling procedure). (D) Marker expression 
profiles analysed by flow cytometry showing a high conformity between ICG-labeled and unlabeled 
MSCs. A basic characterization of the primary murine stem cells was provided through the analysis 
of different surface markers defining the MSC profile (CD44+, CD90+, CD29+, CD105+, Sca-1+, and 
CD11b-).  
 
MSCs Detachment Suspension ICG-Labeling
In vivo 
transplantation 
and detection
Laser excitation US emission
A
B C
2 15 30 60 180 360
0
20
40
60
80
100
120
C
e
ll
 v
ia
b
il
it
y
, 
[%
]
Incubation time, [min]
 Culture medium          ICG labeling
**
**
0 1 2 3 4 5 6 7 8 9
0
5
10
15
20
25
30
35
40
 
**
 
P
ro
li
fe
ra
ti
o
n
 r
a
te
, 
N
t/
N
0
Incubation time
 0 h    0.5 h   
 1 h    3 h
 6 h
Time, [days] 
**
0
20
40
60
80
100
CD
29
CD
11
b
P
o
s
it
iv
e
 c
e
ll
s
 [
%
]
Sc
a-1
 Unlabeled MSCs          ICG-labeled MSCs
CD
10
5
CD
90
CD
44
D
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
Journal header will be provided by the publisher 10 
 
 Copyright line will be provided by the publisher 
 
PBS               ICG     15 µM                50 µM                  100 µM 1 mM
Cells              PBS          ICG 15 µM             50 µM            100 µM 1 mM
ICG-labeled MSCs (cells/µl) 
3000                       4000                    6000               15000 
Unlabeled
MSCs
M
er
ge
P
A
U
S
A
DC
B
FE
M
e
rg
e
P
A
U
S
M
e
rg
e
P
A
U
S
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
*
**
 
15000 
cells/l
Average3000
 cells/l
1 mM 100 M 
Internalized into cellsMixed with cells
N
o
rm
a
li
z
e
d
 P
A
 I
n
te
n
s
it
y
 [
a
.u
.]
100 M 
ICG
700 750 800 850 900 950
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
 15 uM
 50 uM
 100 uM
 1 mM
N
o
rm
a
li
z
e
d
 P
A
 I
n
te
n
s
it
y
 [
a
.u
.]
Excitation wavelength [nm]
700 750 800 850 900 950
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
2.2
2.4
N
o
rm
a
li
z
e
d
 P
A
 I
n
te
n
s
it
y
 [
a
.u
.]
Excitation wavelength [nm]
 15 uM
 50 uM
 100 uM
 1 mM
700 750 800 850 900 950
0.0
0.3
0.6
0.9
1.2
1.5
1.8
2.1
2.4
2.7
3.0
N
o
rm
a
li
z
e
d
 P
A
 I
n
te
n
s
it
y
 [
a
.u
.]
Excitation wavelength [nm]
 3000 cells/l
 4000 cells/l
 6000 cells/l
 15000 cells/l
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
Journal header will be provided by the publisher 11 
 
 Copyright line will be provided by the publisher 
Figure 2. In vitro PA imaging of ICG. Photoacoustic spectra (A, C, and E) and representative 
imaging (B, D, and F) in pure photoacoustic mode (PA), ultrasounds (US) or merged imaging of: 
aqueous ICG solutions at different concentrations (A and B), 3.0×105 unlabeled MSCs resuspended 
in differently concentrated ICG solutions (C and D) and 3.0×105
 
ICG-labeled MSCs resuspended at 
different cell concentrations in PBS (E and F). (G) PA signal quantification at fixed wavelength (810 
nm) of ICG in free form, in the presence of cells, and internalized into cells after labeling. ‘Average’ 
refers to average value of signal from all cell densities conditions. Statistical significance was 
determined by the unpaired Student t-test.  
 
 
Figure 3. In vitro optical imaging of ICG. Fluorescence intensity (as expressed in average radiant 
efficiency) and representative imaging of aqueous ICG solutions at different concentrations either in 
the absence or in the presence of 3.0×105 unlabeled MSCs (A and B), and differently concentrated 
suspensions of ICG-labeled MSCs (C and D).   
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Figure 4. In vivo local PA Signal Intensity after cell transplantation. (A) Representative B-Mode 
Ultrasound imaging showing the deposition site of 3.0×105 unlabeled MSCs after intramuscular 
transplantation. (B) Representative combined Ultrasound and Photoacoustic (US/PA) images 
recorded at the PA excitation wavelength of 810 nm, showing the inoculation site before and after 
the transplantation of 3.0×105 ICG-labeled MSCs (right hindlimb, top), or an equivalent number of 
control unlabeled cells (left hindlimb, bottom). (C) Photoacoustic spectra recorded in the inoculation 
site at variable time ranges after cell deposition, expressed as Photoacoustic enhancement (PA Enh) 
over the control unlabelled cells. (D) Shape of the photoacoustic spectra recorded at time points 
starting from day 1. (E) Excitation wavelength of the main peak in the PA spectra during monitoring. 
(F) Photoacoustic contrast enhancement measured at the excitation wavelength of 810 nm and at that 
corresponding to the maximum spectral peak. (G) Representative PA monitoring (fixed excitation 
wavelength: 810 nm) of the cell engraftment over days. ROIs were drawn on the muscular region 
(internal area of the hindlimb), excluding the unspecific signal generated by the skin-induced 
reflection artefacts (tissue depth ≤ 1mm). 
 
 
 
 
Figure 5. In vivo optical imaging. Fluorescence signal intensity measured after the transplantation 
of 3.0×105 ICG-labeled MSCs (excitation and emission wavelengths: 745 and 840 nm, respectively) 
and expressed as Fluorescence Imaging Enhancement (FLI Enh) over the control unlabeled cells (A). 
Representative optical images showing the time persistence of the fluorescent signal after the cell 
transplantation (color scale: 2.0×108-4.0×109 for images in the top row, 4.0×107-2.0×109
 
for images 
in the bottom row) (B). Calibration bars are shown.  
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